Crucial Role of Endogenous Interleukin-10 Production in Myocardial Ischemia/Reperfusion Injury
Why the study?
Does endogenous IL-10 protect the ischemic and reperfused myocardium?
Population
Ischemic and reperfused myocardium model
Design
Preclinical
Authors
Discussion
Loading...
Member takes
Implication
May inform anti-inflammatory strategies in myocardial I/R injury; leaves open whether IL-10 modulation translates to human cardioprotection.
Key Points
- The aim is to investigate how endogenous IL-10 affects inflammation and injury in myocardial ischemia/reperfusion.
- Direct evidence collected regarding IL-10 production.
- Assessment of tumor necrosis factor-alpha and nitric oxide levels during ischemia/reperfusion.
- Evaluation of neutrophil recruitment in the myocardium.
- Endogenous IL-10 significantly inhibits tumor necrosis factor-alpha production.
- IL-10 reduces nitric oxide production in the ischemic myocardium.
- Suppression of neutrophil recruitment was observed with increased IL-10 levels.
Structured PICO
Does endogenous IL-10 protect the ischemic and reperfused myocardium?
P
Population
Ischemic and reperfused myocardium model
I
Intervention
Endogenous IL-10
O
Outcome
Production of tumor necrosis factor-alpha and NO, myocardial protection, and neutrophil recruitmentsurrogate
Endogenous IL-10 plays a crucial protective role in myocardial ischemia/reperfusion injury by suppressing inflammatory mediators and neutrophil recruitment.
Cite This Study
Yang et al. (2000) studied this question.